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ABSTRACT 
 
For decades it was thought that cells that lost in the human central nervous system because of 
ageing or disease – different from other cell tissues – cannot be replaced and that in humans 
all neurons are generated during prenatal development. However, over the last 20 years, it 
became obvious that there is a certain level of adult neurogenesis in most mammals that 
mainly occurs in the dentate gyrus and the subventricular zone. Whether or not findings from 
animal studies also hold true in humans was difficult to study as direct evidence – as obtained 
in animals from genomic labeling using for instance nucleosides like BrdU – was not feasible 
in humans because of ethical considerations. The establishment of the so-called radiocarbon 
technique, a method taking advantage of the above-ground nuclear bomb tests during the 
Cold War to retrospectively birth date cells by determination of the 12C/14C ratio in genomic 
DNA – allowed to investigate the age and the turnover dynamics of cells in various human 
tissues. Applying this technique we here (i) studied whether there is adult neurogenesis in the 
healthy human brain, specifically within the hippocampus, (ii) studied whether there is adult 
neurogenesis in the diseased human brain, specifically in response to cortical stroke, and (iii) 
investigated the age and growth dynamics of brain tumors, specifically benign meningiomas. 
In essence we demonstrate (i) that there is a lifelong adult neurogenesis within the human 
hippocampus and provide an integrated model of hippocampal cell turnover dynamics, (ii) 
that there is no significant induction of cortical neurogenesis following ischemic cortical 
stroke in humans, and (iii) that the age of benign meningiomas is significantly older than that 
of more malignant brain tumors. The clinical implications of these findings are discussed and 
research projects for future studies identified.   
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1 INTRODUCTION 
 
1.1.                   Cell turnover in the adult human brain 
 
An emerging field at the interface of basic science and clinical research is regenerative 
medicine (Okano, 2010; Steiner et al., 2006). Although not mandatory for functional 
recovery, the generation of new cells is linked to increased regenerative capacity of various 
tissues (Farkas and Huttner, 2008; Koch et al., 2009; Merkle and Alvarez-Buylla, 2006; 
Okano, 2010). Hence, many investigations aim at understanding the characteristics and 
behavior of stem and progenitor cells to study mechanisms and techniques to regenerate cells 
and tissues that may have been lost as a consequence of disease (Barnabe-Heider and Frisen, 
2008; Dietrich and Kempermann, 2006; Emsley et al., 2005; Johansson et al., 2010; 
Kriegstein and Alvarez-Buylla, 2009; Ninkovic and Gotz, 2007; Okano and Sawamoto, 2008; 
Scheffler et al., 2006; Steiner et al., 2006).  
 
1.1.1. Adult neural stem and progenitor cells 
 
The beginning of human life is the fertilized oocyte (Kempermann, 2011). From this 
totipotent stage a blastocyst is formed and embryonic stem cells – being pluripotent – emerge 
(Kempermann, 2011; Kriegstein and Alvarez-Buylla, 2009). Upon further maturation somatic 
stem cells originate, categorized within the endo-, meso-, and ectoderm (Kriegstein and 
Alvarez-Buylla, 2009). Focussing on the development of the human central nervous system 
(CNS), the neuroectoderm contains neuroepithelial cells, which are the primary neural stem 
cells (Farkas and Huttner, 2008; Kempermann, 2011; Koch et al., 2009). Characteristics of 
many somatic stem cells are self-renewal and multipotency (Goritz and Frisen, 2012; 
Kempermann, 2011). There are also progenitor cells, which in the developing CNS comprise 
some radial glia and the intermediate progenitor cells, and which usually are more 
proliferative and do not show unlimited self-renewing capacity (Götz and Barde, 2005; 
Kempermann, 2011).  
 
In the context of investigating cell turnover in the human CNS, neural stem and progenitor 
cells have been intensely studied and have been characterized in both the embryonic and 
adult CNS (Kriegstein and Alvarez-Buylla, 2009; Merkle and Alvarez-Buylla, 2006; Okano 
and Sawamoto, 2008). On the one hand, in order to explore the development of the 
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mammalian CNS, there have been extensive analyses of embryonic neural stem cells and 
progenitor cells (Farkas and Huttner, 2008; Jakovcevski and Zecevic, 2005; Okano and 
Sawamoto, 2008). On the other hand, insights into postnatal processes in the mammalian 
CNS have been obtained from the discovery and subsequent characterization of adult 
neurogenesis (see 1.2.) (Dietrich and Kempermann, 2006; Falk and Frisen, 2005; Zhao et al., 
2008). The adult human brain contains a variety of neural progenitor cells, i.e. neuronal and 
glial progenitors, as well as certain radial glial cells and astrocytes that serve as neural stem 
cells (Kempermann, 2011; Kriegstein and Alvarez-Buylla, 2009). Adult neurogenesis 
involves the divisions of adult neural stem cells, resulting in (i) self-renewal and (ii) the 
generation of downstream neural progenitor cells, which then undergo amplification and give 
rise to post-mitotic neurons (Kempermann, 2011; Kriegstein and Alvarez-Buylla, 2009).  
 
A basic model describing the process from a neural stem cell to a post-mitotic neuron is 
shown in Figure 1; a neural stem cell gives rise to neural progenitor cells that in turn generate 
immature neurons which then mature to post-mitotic neurons (Kempermann, 2011).   
----------------------------------------------------------------------------------------------------------------- 
Figure 1. Basic model of adult neurogenesis in the hippocampus.  
 
 
Proposed basic model of cell types in adult hippocampal neurogenesis based on morphology and molecular 
markers. The putative stem cell exhibits radial glia and astrocytic properties and progresses over three stages 
of putative transiently amplifying progenitor cells which increase their neuronal lineage determination, 
followed by the post-mitotic stage. Reprinted from Kempermann et al. (Kempermann et al., 2004a) with 
permission from Elsevier. 
----------------------------------------------------------------------------------------------------------------- 
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1.1.2. Cancer stem cells in brain tumors 
 
Besides stem cells that are present to maintain the function of our organs, in malignant 
diseases the concept of cancer stem cells has been proposed (Lathia et al., 2015; Singh et al., 
2004; Venere et al., 2011). Essentially all tumors, and specifically malignant hematopoetic 
diseases, arise from cancer stem cells that show similar characteristics as somatic stem cells, 
such as self-renewal and differentiation into various tissue types (Singh et al., 2004; Venere et 
al., 2011). Cancer stem cells have been implicated in brain tumors, which coined the term 
brain tumor stem cells (Schonberg et al., 2014; Zhang et al., 2006a). The two most frequently 
occurring brain tumors are gliomas and meningiomas (Riemenschneider et al., 2006; Whittle 
et al., 2004; Wiemels et al., 2010), and tumor generation and resistance to treatment of most 
malignant variants of glioma and meningiomas have been linked to these stem cells (Bao et 
al., 2006).   
 
1.2. Neurogenesis in the adult mammalian brain 
 
It has long been thought that the neurons in the adult mammalian CNS are all those that were 
generated during development (Rakic, 1985, 2002, 2006). However, during the past two 
decades there has been an enormous progress both in animal and human research establishing 
that new neurons are continuously generated in at least two regions of the adult brain 
(Bergmann and Frisen, 2013; Bergmann et al., 2015; Curtis et al., 2011; Eriksson et al., 1998; 
Ernst and Frisen, 2015; Falk and Frisen, 2005; Goritz and Frisen, 2012; Kempermann et al., 
2004a; Lie et al., 2004; Zhao et al., 2008). Thus, adult neurogenesis occurs on the one hand in 
the dendate gyrus of the hippocampus and on the other hand in the subependymal zone of the 
lateral ventricle (Bergmann et al., 2015; Goritz and Frisen, 2012; Kempermann, 2011).  
 
1.2.1. Methodological approaches 
 
Experimental approaches to study adult neurogenesis in the mammalian brain mainly relied 
on immunohistochemical analyses, i.e. on investigating molecular markers of cell 
proliferation, and using nucleosides to label newly synthesized DNA (Bergmann et al., 2015; 
Eriksson et al., 1998; Taupin, 2007; Wang et al., 2011). In both rodents and humans the 
analysis of molecular markers provides insights into cell proliferation and allows labelling of 
stem and progenitor cells at a given time-point. However, several shortcomings limit the 
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interpretation of results (Eriksson et al., 1998; Taupin, 2007). First, the widely used marker 
DCX has been found in cells that differentiated into glial cells (Kempermann, 2011; Klempin 
et al., 2011; Seidenfaden et al., 2006). Second, the analysis of molecular markers that label 
neuronal precursor cells or neuroblasts (defined as cells committed to the neuronal lineage 
but lacking mature neuronal characteristics) does not provide insight into whether or not these 
cells become mature neurons which survive long-term and are of functional significance 
(Kempermann et al., 2004b; Steiner et al., 2006; Zhao et al., 2008). Furthermore, the potential 
number of neurons that these cells generate, and into which specific regions neurons migrate 
during maturation, cannot be answered, thus making this approach difficult for drawing 
definite conclusions on neurogenesis (Bergmann et al., 2015; Ming and Song, 2011).  
 
The second approach involves an analysis of genomic DNA, usually taking advantage of 
nucleosides such as tritiated thymidine or BrdU/EdU and their stable incorporation into the 
DNA when it is duplicated during S-phase (Dolbeare, 1996). In addition, other strategies 
employ labelling with retroviruses or transgenic approaches (Feliciano and Bordey, 2013). 
The basic idea is to introduce a stable mark in cells that is specific for DNA synthesis (e.g. 
incorporation of BrdU) and then explore whether such mark is present in mature neurons, as 
this would indicate true neurogenesis (Jin et al., 2001; Parent et al., 2002; Taupin, 2007). 
Although this approach is more conclusive in demonstrating the occurrence of neurogenesis, 
there are also some drawbacks. For instance, a BrdU pulse may underestimate the number of 
newborn cells as only cells in the S-phase of the cell cycle may have been labeled (Eriksson 
et al., 1998; Magavi et al., 2000). In this regard false-negative and also false-positive 
findings (over- and underdosing of BrdU) on neurogenesis have been published (Breunig et 
al., 2007; Karpowicz et al., 2005; Kunz and Kohalmi, 1991). Furthermore, BrdU 
incorporation into DNA may also occur in non-proliferating cells as a result of DNA repair 
(Burns et al., 2007; Feliciano and Bordey, 2013; Taupin, 2007). Finally, although this 
approach allows prospective labeling of newborn neurons revealing the generation and 
integration of mature neurons in specific brain regions, it is not possible to retrospectively 
determine cell turnover in the adult brain. 
 
Most importantly, however, the toxicity of labeled nucleosides limits their use for studies in 
humans for ethical reasons (Bergmann et al., 2015; Kuhn et al., 1996). There is only one 
seminal study on 5 cancer patients in whom labeled nucleosides were used (see 1.2.2.) 
(Eriksson et al., 1998), and it revealed the “dilemma” that one has to wait until the person 
dies until the brain can be analyzed. Hence, basically all findings regarding adult 
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neurogenesis in the healthy and diseased human brain (see 1.2.2. and 1.2.3.) were derived 
from immunohistochemical analyses. Contrary to animal studies in which one can combine 
the approach of studying molecular markers with the technique of labeling DNA to increase 
the certainty of the findings obtained (Feliciano and Bordey, 2013; Kokaia and Lindvall, 
2012), in humans there is the necessity of novel approaches in addition of 
immunohistochemistry to study neurogenesis in humans, such as the radiocarbon technique 
(see 1.3.) (Bergmann et al., 2015; Ernst and Frisen, 2015; Lindvall and Kokaia, 2015). 
 
1.2.2. Findings in the healthy brain of rodents and humans 
 
In the adult mammalian brain there are at least two neurogenic niches in which lifelong adult 
neurogenesis has been described, that is the subgranular zone (SGZ) of the gyrus dentus of 
the hippocampus and the subventricular zone of the lateral ventricle (Bergmann et al., 2015; 
Goritz and Frisen, 2012; Kempermann, 2011). 
 
Hippocampal adult neurogenesis 
Adult hippocampal neurogenesis has been intensely studied in rodents (Ekdahl et al., 2009; 
Fabel and Kempermann, 2008; Kempermann, 2012; Kempermann et al., 2004a; Klempin et 
al., 2010; Klempin et al., 2011; Lugert et al., 2010; Wolf et al., 2010). The precursor cells of 
the dentate gyrus are located within the SGZ that provides a neurogenic microenvironment 
that is often referred to as neurogenic niche (Kempermann, 2011). The SGZ contains 
astrocytes resembling radial glial cells that represent the stem cells of this area (Kempermann, 
2011; Seri et al., 2001), which in sequence give rise to radial glia-like precursor cells, glia-
like transient amplifying progenitor cells, neuronally determined transient amplifying 
progenitor cells, and migratory neuroblasts (Kempermann, 2011; Kempermann et al., 2004a). 
The phase of post-mitotic maturation – eventually including neuroblasts – is characterized by 
dendritic maturation, axon elongation and synaptic plasticity (Kempermann, 2011).  
 
In rodents the average adult hippocampal neurogenesis amounts to up to 0.03-0.06% per day 
in 2 month old mice, and there is an almost 10-fold decline in adult neurogenesis in mice with 
increasing age between 2 and 9 months (Ben Abdallah et al., 2010; Kempermann et al., 
1997a, b). Besides to in vivo imaging studies, in humans neurogenesis is mainly studied by 
analysis of molecular markers, such as DCX, Ki-67 or NeuN (Attardo et al., 2010; Bergmann 
et al., 2015; Coras et al., 2010; Kempermann, 2012; Knoth et al., 2010). For instance, 
Kempermann and coworkers studied the pattern of DCX-positive neuroblasts in the human 
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dentate gyrus in individuals of all ages and found DCX-positive cells over the entire life, and 
some DCX-positive cells, notably in young individual, showed features of immature neurons 
(Bergmann et al., 2015; Knoth et al., 2010). Further markers of proliferation such as Ki-67 
and surrogate markers of neurogenesis such as Mem2, Prox1 and calretinin, were expressed 
during human adulthood (Knoth et al., 2010). In humans there was also a decrease in DCX-
NeuN-positive cells with increasing age, though this decrease in neurogenesis is probably not 
as high as in rodents (Ben Abdallah et al., 2010).  
 
Prior to our study (see 3), the seminal study by Eriksson and colleagues provided the most 
robust evidence of human hippocampal neurogenesis (Eriksson et al., 1998). Using a single 
infusion dose of BrdU, administered for diagnostic purposes in patients with oropharyngeal 
cancer, they were able to demonstrate the presence of BrdU in hippocampal neurons that 
verified the presence of adult born neurons in the human hippocampus (Bergmann et al., 
2015; Eriksson et al., 1998; Falk and Frisen, 2005). This study was of enormous significance 
as it proved the existence of adult neurogenesis in humans. However, it did not enable any 
quantitative estimates and was not addressed to clarify the functional significance 
(Kempermann, 2012; Lucassen et al., 2010; Rakic, 1985). 
 
Neurogenesis in the SVZ, striatum and olfactory bulb 
The second neurogenic niche in mammals is the SVZ (Benraiss et al., 2001; Curtis et al., 
2007; Ekdahl et al., 2009; Hansen et al., 2010; Komitova and Eriksson, 2004; Reillo et al., 
2010; Sanai et al., 2004; Seidenfaden et al., 2006; Wang et al., 2011). In rodents the SVZ is a 
very tiny, approximately two-cell-body-wide layer below the ependymal cell layer, which is 
why the SVZ is also referred to as subependymal layer (Kempermann, 2011). The putative 
progenitor cells are radial astrocytes, which extend their primary cilium into the ventricles 
with direct contact with the ventricular fluid, which is why the term “periventricular region” 
may be most appropriate (Beckervordersandforth et al., 2010; Kempermann, 2011; Sanai et 
al., 2011; Weigmann et al., 1997). Neurogenic progenitor cells of this system, however, also 
are found within the rostral migratory stream (RMS) and in the olfactory bulb (OB) (see 
below) (Curtis et al., 2007; Wang et al., 2011).  
 
In the rodent brain there are many neuroblasts migrating from the SVZ to the OB every day 
(Bergmann et al., 2015; Doetsch et al., 1997; Ming and Song, 2011; Ponti et al., 2006). 
Within the OB there is a differentiation to interneurons followed by an integration into the 
existing neuronal circuits, and studies demonstrated that about 40% of these newborn neurons 
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survive long-term (Winner et al., 2002) and are functionally relevant, participating in 
olfactory memory (Ming and Song, 2011). Other neuroblasts are also found in the striatum, 
and low levels of striatal neurogenesis have been reported in rodents but also in monkeys 
(Bedard et al., 2002a; Bedard et al., 2002b; Dayer et al., 2005; Luzzati et al., 2003; Tonchev 
et al., 2005). Whether or not these cell originated in the SVZ and eventually migrated towards 
the striatum is currently under investigation (Magnusson et al., 2014) (and personal 
communication). Although difficult to study, there might be a decline in OB neurogenesis 
with mammalian evolution (see below for humans), potentially related to a corresponding 
concomitant increase of respective striatal neurogenesis. However this remains speculative 
(Bergmann et al., 2015).   
 
In the human brain the existence of SVZ, RMS and OB adult neurogenesis is much more 
controversial (Curtis et al., 2011; Curtis et al., 2007; Sanai et al., 2007). There were studies 
confirming this process also in the human fetal and infant brain; however, the migratory 
neuroblasts and transiently amplifying cells were not detected in adults, or dividing 
neuroblasts detected by immunolabeling existed only at very low levels (Bergmann et al., 
2015; Sanai et al., 2011). Recently, a human study using the radiocarbon technique (see 1.3.) 
revealed the absence of significant (<1% over 100 years) OB neurogenesis (Bergmann et al., 
2012). Hence the question arose as to what the fate of SVZ progenitors is humans, as there 
has been reported no significant apoptosis of SVZ neuroblasts (Ernst et al., 2014; Ernst and 
Frisen, 2015). DCX- and PSA-NCAM-positive neuroblasts have been found in the human 
striatum next to the SVZ (Ernst et al., 2014); however, it remains speculative whether these 
were derived from the SVZ (Bergmann et al., 2015). Recently, a human study using the 
radiocarbon technique (see 1.3.) revealed generation of striatal interneurons at levels of 2.7%  
per year; however, the origin of these cells as well as their functional significance remain to 
be established (Ernst et al., 2014).  
 
Neurogenesis in the cerebral cortex 
The cerebral cortex harbors the higher cognitive functions, and disease affecting the human 
cortex is directly linked to severe neurological impairment (Buffo et al., 2008). Hence, in the 
context of adult neurogenesis, it has been hotly debated whether or not the cerebral cortex has 
any neurogenic potential (Bhardwaj et al., 2006; Feliciano and Bordey, 2013; Rakic, 2006). 
Some researchers believe that the dogma that all neurons are generated prenatally at least 
holds true for the cerebral cortex. In line with this notion, various reports in rodents and 
humans have failed to provide any immunohistochemical evidence for a significant 
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occurrence of progenitor cells or newly generated neurons in the neocortex (Ehninger and 
Kempermann, 2003; Kornack and Rakic, 2001; Tamura et al., 2007). A study based on the 
radiocarbon approach (see 1.3) demonstrated that there is no significant postnatal 
neurogenesis (Bhardwaj et al., 2006). This investigation was supported by a retrospective 
assessment of BrdU and its colabeling with neuronal markers in tissue samples of the 
Eriksson study of 1998 (Bergmann et al., 2015; Bhardwaj et al., 2006; Eriksson et al., 1998). 
Based on this combined approach the authors concluded that adult neurogenesis in the human 
cerebral cortex, if there is any at all, amounts to a maximum of one newborn neuron out of 
1000 neurons every five years (Bergmann et al., 2015; Bhardwaj et al., 2006). On the other 
hand there are also studies reporting on cortical neurogenesis, though at very low levels 
(Bernier et al., 2002; Dayer et al., 2005; Gould et al., 2001; Luzzati et al., 2003). Studies 
using tritiated thymidine found neurogenesis rates of 0.011% (Altman, 1969; Kaplan, 1981), 
and analysis of BrdU/NeuN-co-labeling reported on rates of 0.0026-0.012% in monkeys, or 3 
newborn neurons per mm3 in rats (Dayer et al., 2005). In this regard it needs to be mentioned 
that long-term neuron survival and the functional significance of potential neurogenesis has 
not been addressed; occurrence of preferentially small GABAergic interneurons instead of 
projections neurons may occur only transiently (Gabbott and Bacon, 1996; Gould et al., 
2001). In conclusion, it remained controversial if there is any neurogenesis in the mammalian 
cerebral cortex at all. Furthermore, while the functional significance is questionable in the 
healthy situation, there may be a mechanism of possible induction of cortical neurogenesis 
upon neurological disease (Jin et al., 2006). 
 
1.2.3. Findings after cerebral ischemia in rodents and humans 
 
Within established neurogenic niches (hippocampus and SVZ) 
Histological changes in response to stroke have been intensely studied in animals and – given 
the methodological problems in humans – only in a limited way in humans (Kokaia and 
Lindvall, 2012; Lindvall and Kokaia, 2015). While there are essentially no studies addressing 
changes in hippocampal adult neurogenesis following stroke in humans, in rodents there have 
been various analyses demonstrating an increase in the hippocampal neurogenesis rate after 
stroke (Geibig et al., 2012; Jin et al., 2001; Kernie and Parent, 2010; Zhao et al., 2008; Ziv et 
al., 2007). These investigations were mainly based on co-labelling with BrdU and NeuN, and 
reported increased rates of such double-positive cells in the hippocampus ipsilateral to the 
focal cerebral injury (Geibig et al., 2012). Also within the SVZ, experimental stroke in 
rodents induced proliferation and neurogenesis (Arvidsson et al., 2002; Jin et al., 2001; Parent 
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et al., 2002; Zhang et al., 2001). Still of debate is whether this increase in SVZ neurogenesis 
is transient (Arvidsson et al., 2002; Parent et al., 2002) or persisting (Thored et al., 2006). In 
humans a similar neurogenic response has been postulated in terms of an increased number 
of Ki-67-positive cells and periventricular neural progenitors in the SVZ ipsilateral to the 
ischemic lesion (Macas et al., 2006; Marti-Fabregas et al., 2010). 
 
Within brain regions that are non-neurogenic in healthy conditions (striatum and cortex) 
There is a body of evidence that stroke can induce the generation of new neurons in brain 
regions where – in the healthy physiological setting – there is no adult neurogenesis (see 
above), specifically the striatum and the cerebral cortex (Jiang et al., 2001; Jin et al., 2003; Jin 
et al., 2006; Leker et al., 2007; Lindvall and Kokaia, 2015; Tonchev et al., 2005; Ziv et al., 
2007). Within the striatum of rodents BrdU-positive neuronal progenitors and mature neurons 
have been identified by co-labelling BrdU-postive cells with  DCX and NeuN (Arvidsson et 
al., 2002; Parent et al., 2002). Notably, on the one hand, the BrdU-positive cells that co-
labeled positive for DCX during the course of the disease expressed NeuN, reflecting 
neuronal maturation. On the other hand, some of these cells expressed transcription factors 
that indicated differentiation into projection neurons (Arvidsson et al., 2002). Focussing on 
the source of these cells, recent evidence showed that neuroblasts originate from both, SVZ 
astrocytes migrating into the ischemic striatum, and latent neurogenic striatal astrocytes 
(Magnusson et al., 2014). The latter mechanism is inhibited in the healthy setting by 
Notch1 signaling; however, the functional relevance of striatal endogenous adult 
neurogenesis in response to stroke needs to be further established (Magnusson et al., 2014).  
 
Whether or not stroke induces neurogenesis in the cerebral cortex is less studied and also 
controversial (Kernie and Parent, 2010; Lindvall and Kokaia, 2015). In studies on rodent 
striatal neurogenesis there had been no evidence of any significant cortical neurogenesis 
after cortical ischemia (Arvidsson et al., 2002; Parent et al., 2002; Zhang et al., 2001). 
Contrary, some immunohistochemical studies reported on new neuroblasts and mature 
neurons in the cerebral cortex after cortical ischemia (Jiang et al., 2001; Jin et al., 2006; 
Zhang et al., 2006b; Ziv et al., 2007). Furthermore, cortical neurogenesis following stroke 
may be induced by growth factors (Leker et al., 2007; Taguchi et al., 2004). Addressing to 
the origin of these neurons, Jin and colleagues described DCX-positive neuroblasts 
migrating from the SVZ to the periphery of the cortical ischemia (Jin et al., 2003; Osman et 
al., 2011). In humans, there are also conflicting analyses; however, there is growing 
evidence from immunohistochemical studies reporting on DCX-positive cells in the vicinity 
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of cortical blood vessels after stroke, as well as cells expressing nestin (Jin et al., 2006; 
Marlier et al., 2015; Minger et al., 2007; Nakayama et al., 2010). Debate remains whether 
these cells originated from activation of dormant neural stem cells residing within the 
cerebral cortex that gave rise to neuroblasts after cortical ischemia (Jiang et al., 2001; Magavi 
et al., 2000; Yang et al., 2007). 
 
1.3. Radiocarbondating to study cell turnover in the human brain 
 
1.3.1. The technique of 14C-retrospective birth dating of cells 
 
To overcome the difficulties described above in assessing adult neurogenesis in humans, the 
research group led by Prof. Jonas Frisén at the Karolinska Institute developed a clever 
method to retrospectively birth date cells in humans (Spalding et al., 2005a). The so-called 
radiocarbondating – also known from archaeology to date historical finds (Arlotta and 
Macklis, 2005) – represents a technique which basically analyzes carbon (Spalding et al., 
2005a). Carbon usually exists as the isotope 12C (Arlotta and Macklis, 2005); however, within 
the atmosphere there is also a small amount of the carbon isotope 14C (usually as 14CO2) (De 
Vries, 1958) that naturally occurs in the setting of cosmic radiation colliding with nitrogen 
nuclei (De Vries, 1958; Stuiver and Polach, 1977). The ratio between both isotopes 
historically was relatively constant over decades until 1955-63 when 14C levels were 
drastically increased upon the above-ground nuclear bomb testing during the Cold War 
(Nydal and Lovseth, 1965; Stuiver and Polach, 1977) (Figure 2). After the test ban treaty in 
1963, the 14C levels started to decline again mainly because of diffusion from the atmosphere 
and binding in the oceans (Harkness, 1972; Libby et al., 1964; Nowakowski, 2006; Nydal and 
Lovseth, 1965). Importantly, the time resolution of the radiocarbon-technique since the bomb 
peak in the 14C level and its subsequent decline became very precise as compared to the time 
prior of the nuclear bomb testings (Harkness, 1972; Spalding et al., 2008; Spalding et al., 
2005a; Spalding et al., 2005b; Stuiver and Polach, 1977).   
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Figure 2. Atmospheric changes of 14C/12C ratio caused by nuclear bomb tests. 
 
 
 
Ratio of atmospheric carbon isotopes 14C and 12C during the last century (Libby et al., 1964; Nowakowski, 2006; 
Nydal and Lovseth, 1965; Stuiver and Polach, 1977). Upon the above-ground nuclear bomb tests during the Cold 
War there was a dramatic increase in the atmospheric levels of 14C which declined since the Test Ban Treaty in 
1963. The blue line indicates 14C/12C ratio of the Northern hemisphere, the red line of the Southern hemisphere. 
----------------------------------------------------------------------------------------------------------------- 
 
The released atmospheric 14C reacts with oxygen and forms CO2 which enters the food chain 
upon plant photosynthesis (Bergmann et al., 2009). By eating plants, and animals that live of 
plants, the 14C concentration in the human body – being at the top of the food pyramid – 
closely corresponds to that in the atmosphere at any given time (Spalding et al., 2005a). If 
there is cell turnover, the newly synthesized DNA – which consists of roughly one third of 
carbon – incorporates exactly this carbon ratio of 12C/14C which was present in the 
atmosphere at the time-point the cell was generated (Spalding et al., 2005a). Hence, as the 
DNA is stable after a cell has gone through its last cell division, the genomic 14C levels serve 
as a date mark for when a cell was born and can be used to retrospectively birth date cells in 
humans (Bergmann et al., 2009; Bhardwaj et al., 2006; Spalding et al., 2005a) (Figure 3).  
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Figure 3. Concept of 14C retrospective birth dating of cells.  
 
 
 
The principle of 14C retrospective birth dating of cells. Nuclear bomb detonations released 14C into the 
atmosphere which formed 14CO2 and entered the food chain by photosynthesis of plants. By eating plants 14C 
was ingested by animals and humans. Upon generation of a new cell, DNA is synthesized which consists 
roughly of one third carbon. Almost exactly the 14C/12C ratio that was present in the atmosphere in the year a cell 
was generated was incorporated into the newly synthesized DNA, acting as a stable date mark (Spalding et al., 
2005a). By extracting DNA from cell populations of interest (e.g. neurons) and analyzing the 14C/12C ratio, the 
average age of the cell population under investigation can be determined.  
----------------------------------------------------------------------------------------------------------------- 
 
The radiocarbon technique requires to first isolate the DNA of the targeted cell population 
(Spalding et al., 2005a). Human tissue samples may be obtained upon biopsy or – which was 
the case so far – upon post mortem autopsies (Bergmann et al., 2009; Bhardwaj et al., 2006; 
Ernst et al., 2014). The methodological approach includes the isolation of cell nuclei in a first 
step which usually is achieved by sucrose gradient centrifugation (Bergmann et al., 2012; 
Huttner et al., 2014). Using molecular markers that specifically label the nuclei of the target 
cell population, these nuclei are isolated by flow cytometry (Bergmann et al., 2009; Ernst et 
al., 2014). Subsequently, and constituting the most tricky part of the technique, the DNA 
needs to be isolated: this is performed in clean rooms to minimize contamination with 
contemporary carbon (Bergmann et al., 2009; Spalding et al., 2013). Finally, the isolated 
DNA is analyzed by accelerator mass spectrometry to determine the amount of the various 
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carbon isotopes within the sample (Spalding et al., 2005a). The interpretation of results is 
schematically explained in Fig. 4. 
----------------------------------------------------------------------------------------------------------------- 
Fig. 4. Interpretation of radiocarbon technique. 
 
Figure 4: Interpretation of 14C-data obtained; Individual born after (A) and before (B) the bomb peak. The 
vertical line represents the year of birth of the individuals. First, the 14C concentration in genomic DNA from a 
given cell population is measured using mass spectrometry. Second, the 14C-value obtained is interpreted in 
relation to the atmospheric 14C curve (blue) and plotted (red dot) Then the perpendicular on the X-axis reflects 
the average birth date of the cell population. Reprinted from Spalding et al (Spalding et al., 2005a) with 
permission from Elsevier. 
----------------------------------------------------------------------------------------------------------------- 
 
 
1.3.2.  Implications of radiocarbondating to study cell turnover in the healthy and 
diseased human brain 
 
It is quite remarkable that today we do not yet understand if neuronal turnover plays a role in 
disease, and it is not known what regenerative efforts the brain is capable of making 
following injury. The question whether neural stem cells are activated in the adult brain in 
response to lesions, notably stroke, and generate functional neurons, is of fundamental 
importance for regenerative medicine (Barnabe-Heider and Frisen, 2008; Curtis et al., 2011; 
Minger et al., 2007). Answering this question would be important for identifying diseases 
where therapies directed at modulating cell replacement would be beneficial (Koch et al., 
2009; Lie et al., 2004; Scheffler et al., 2006).  
 
In light of the differences between mouse and human neural stem and progenitor cells that 
have recently been uncovered (Farkas and Huttner, 2008; Fietz et al., 2010; Goldman, 2003; 
Hansen et al., 2010; Kriegstein and Alvarez-Buylla, 2009; Merkle and Alvarez-Buylla, 2006; 
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Reillo et al., 2010), it is unclear to which extent the data from animal models can be 
extrapolated to humans. Moreover, it is possible that the responsiveness of quiescent neural 
stem cells to “wake-up” triggers in the adult human brain differs from that in the adult rodent 
brain (Fancy et al., 2004; Lugert et al., 2010). It is therefore imperative to directly determine 
the sites, and extent, of adult neurogenesis in the human brain under physiological and 
pathological conditions (Buffo et al., 2008; Kempermann et al., 2004b; Magavi et al., 2000). 
The method of 14C-based retrospective birth dating of neurons is at present undisputedly the 
most valid experimental approach to obtain these data (Arlotta and Macklis, 2005).  
 
Previous findings provided proof-of-principle evidence that the method of retrospective birth 
dating of cells can be used to determine the age of neurons in specific brain regions, and 
hence to unequivocally establish the occurrence or absence of human adult neurogenesis. 
Specifically in stroke, given the different pathophysiological cascades and mechanisms 
following the various subtypes of stroke, and in light of the differences in clinical 
significance regarding the location of stroke, it will be important to correlate the 14C data 
obtained on adult neurogenesis in response to stroke to those on functional recovery to 
explore the clinical value of possible neurogenesis (Chopp et al., 2009; Jiang et al., 2001). 
The radiocarbon technique further allows, for the first time, to assess the age of tumor cells 
and to investigate cell turnover dynamics in brain tumors (Spalding et al., 2005a). As the 
sensitivity of the 14C-based approach of birth dating cells is increased the longer the time-
period between an event (e.g. onset of stroke or tumor growth) and the read-out (tissue 
assessment upon biopsy or death) dates back, we decided to analyze tumor growth dynamics 
in meningiomas (Spalding et al., 2005a). This tumor type is thought to grow slowly as 
compared to more malignant glioma variants (Nakamura et al., 2003; Pompili et al., 1998; 
Zeidman et al., 2008).    
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2 AIMS OF THE THESIS 
 
Listed according to publications: 
Applying the technique of 14C retrospective birth dating of cells, the aims of this thesis were: 
I. to investigate whether or not and to which extent there is adult neurogenesis in the 
healthy human brain, specifically within the hippocampus; 
II. to investigate whether or not and to which extent there is adult neurogenesis in the 
diseased human brain, specifically in response to cortical stroke;  
III. to investigate the age and growth dynamics of brain tumors, specifically benign 
meningiomas.  
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3 SUMMARY OF RESULTS  
 
Using the unique opportunity of 14C retrospective birth dating of cells, we have addressed 
three fundamental research questions. First, the cell turnover in the healthy human brain, 
specifically adult neurogenesis within the hippocampus. Second, the cell turnover in the 
diseased human brain, specifically whether or not neurogenesis is induced within the cerebral 
cortex in response to ischemic stroke. Third, we used the 14C-based birth dating technique to 
explore the age and growth dynamics of meningiomas. 
 
In the first publication (Spalding et al., 2013), we for the first time demonstrated that adult 
neurogenesis within the human hippocampus occurs over the entire lifespan and described 
cell turnover dynamics of this process (Spalding et al., 2013). Prior to our study all 
information on human hippocampal neurogenesis was based on immunohistochemical 
analyses, leaving room for uncertainties if the described findings truly reflect neurogenesis in 
terms of maturation and survival of labeled cells (Knoth et al., 2010; Sanai et al., 2011). Only 
the landmark study by Eriksson et al. (Eriksson et al., 1998) had provided direct evidence for 
hippocampal neurogenesis, yet it was based on only few patients and did not address the 
number of newly generated neurons nor cell turnover dynamics within the human 
hippocampus. By determining the genomic 14C-concentration in neuronal and non-neuronal 
DNA, we demonstrated that there is significant hippocampal neurogenesis over the entire 
human lifespan (Spalding et al., 2013) – in contrast to the previously described absence of 
neurogenesis in the healthy cerebral cortex and olfactory bulb (Bergmann et al., 2012; 
Bhardwaj et al., 2006) . We were able to show that hippocampal neurons are exchanged on a 
population level and that not all neurons are exchanged during life. By mathematical 
modeling we suggested the existence of a constantly renewing fraction that constitutes 
approximately 35% of all hippocampal neurons, a number that reflects slightly less neurons 
than known to exist in the dentate gyrus (Spalding et al., 2013). We calculated that the 
median turnover rate of neurons within the renewing subpopulation is 1.75% per year 
during adulthood, which corresponds to ≈700 new neurons per day in each hippocampus or 
0.004% of the dentate gyrus neurons per day in the human hippocampus (Spalding et al., 
2013). Mathematical modeling also suggested that there is a moderate decline in the amount 
of neurogenesis with increasing age. The neuronal turnover rates in humans were 
comparable to previous reports of hippocampal neurogenesis rates in middle-aged mice 
(Ninkovic and Gotz, 2007; Spalding et al., 2013). We concluded that human adult 
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hippocampal neurogenesis may be of functional significance and emphasized that further 
studies in patients with dementia or psychiatric disease may reveal important insights into 
the hippocampal turnover dynamics in disease (Kempermann, 2011; Santarelli et al., 2003).   
 
In the second publication (Huttner et al., 2014), we investigated whether or not neurogenesis 
is induced in the human cerebral cortex following ischemic stroke. Prior to our study, 
knowledge of cortical neurogenesis was mainly based on experimental findings from animal 
studies, with conflicting results (Arvidsson et al., 2002; Jiang et al., 2001; Jin et al., 2006; 
Parent et al., 2002; Zhang et al., 2006b; Zhang et al., 2001; Ziv et al., 2007). For humans 
there were only few immunohistochemical studies that had reported conflicting findings, 
either suggesting no sustained neurogenesis or claiming signs of adult neurogenesis in the 
penumbra of cortical infarcts, predominantly in the vicinity of blood vessels (Jin et al., 2006). 
By measuring the concentration of genomic 14C in cortical neurons after ischemic stroke we 
demonstrated (i) that the age of neurons surrounding the ischemic infarct core is the same as 
that of non-affected neurons of the occipital cortex of the healthy contralateral hemisphere of 
the same individuals (Huttner et al., 2014), and (ii) that this age corresponds to the respective 
age of the patients included into our study (Huttner et al., 2014). We thus provided evidence 
that there is no significant cortical neurogenesis in response to stroke and that the neurons 
surrounding the infarct core are most likely the neurons that were generated during fetal 
development and that survived the stroke (Huttner et al., 2014). We correlated our findings 
with immunohistochemical analyses of lipofuscin, an age pigment constituted of protein and 
lipid clusters that starts accumulating in neurons after 5-10 years and continues to do so 
during life (Benavides et al., 2002); we did not find any lipofuscin-negative neurons, neither 
in healthy regions nor within the ischemic lesion of the cerebral cortex, a finding consistent 
with all neurons being old (Huttner et al., 2014). We further provided evidence that there is 
cell turnover within the non-neuronal population, most likely reflecting the generation of glial 
cells in the process of scar formation, as those cells were of younger age than the non-
neuronal cells of the control areas, i.e. the non-affected occipital cortex (Huttner et al., 2014). 
Interestingly, by performing single cell gel electrophoresis assays, we detected a certain level 
of DNA fragmentation occurring in the early phase after cortical ischemia; in relation to this 
finding we were able to demonstrate that up to 22% of the non-apoptotic neurons were 
positive for DNA repair markers, such as APE-1 and gammaH2AX (Huttner et al., 2014; 
Oezguen et al., 2007; Park et al., 2006). By whole-genome and transcriptome analyses we 
verified the genomic integrity of neurons present in the chronic phase after cortical stroke. 
We concluded that there is no relevant neurogenesis – in terms of neuron maturation and 
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long-term survival – within the human cerebral cortex following ischemic stroke (Huttner et 
al., 2014). 
 
In the third manuscript (Huttner et al.), we used the 14C-based birth dating technique to 
explore the age and growth dynamics of meningiomas. Meningiomas are – together with 
gliomas – the most frequently occurring brain tumors in humans. They arise from arachnoidal 
cap cells and are usually slowly growing and benign (WHO°1); however, there are also 
invasive-malignant atypical variants (Perry et al., 2004; Riemenschneider et al., 2006; Whittle 
et al., 2004). There has been an intensive debate about the age of these tumors; however, 
there has been no methodological approach to explore the onset of tumor growth, and studies 
on growth dynamics were mainly based on imaging findings, e.g. serial magnetic resonance 
imaging (Nakamura et al., 2003; Zeidman et al., 2008). We measured the average 14C-
concentrations of all cells within the tumor – obtained as an aliquot upon surgical resection of 
the tumor – of patients with benign (WHO°1) and atypical (WHO°2) meningiomas, and 
found the average age of tumor cells of WHO°1 meningiomas to date 2.3 - 9.5 years older 
than the time-point of surgery, whereas WHO°2 meningiomas dated as old as the year of 
surgery (this analysis however did not reflect the onset of tumor growth). Based on 
immunohistochemical analyses and confocal microscopy we obtained various parameters 
such as Ki-67 indices, tumor cell densities and apoptosis rates, to integrate – together with the 
14C-data obtained and the imaging findings of tumor size and growth – our findings into a 
mathematical model of meningioma growth dynamics. We were able to identify (i) 
meningiomas that were still residing in the lag phase (i.e. slowly growing but not yet entering 
the exponential growth curve (Huttner et al.)), (ii) meningiomas that were in the exponential 
growth, and (iii) meningiomas that had already entered a plateau phase (Huttner et al.). The 
mathematical modeling allowed us to determine the onset of tumor growth, defined as the 
generation of the first tumor cell. Benign meningiomas were on average 22.1 years old 
(ranging from 10.8-31.1 years), whereas atypical WHO° 2 meningiomas originated 1.5 ± 0.1 
years prior to surgery (Huttner et al.). Further, we noticed a statistically significant difference 
in the age of meningioma subtypes, i.e. meningothelial versus fibrous meningiomas 
(meningothelial: 17.8 ± 5.8 years versus 26.3 ± 4.0 years in fibrous meningiomas; p = 0.015), 
whereas there was no significant correlation of meningioma age with the age of patients (R2 = 
0.0275) or the Ki-67 index (R2 = 0.1539). We concluded that existing models to predict 
meningiomas growth may complement 14C-data on tumor cells to better estimate growth 
dynamics (Huttner et al.). The latter may be of specific clinical relevance in patients with a 
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tumor that is difficult to assess surgically and hence has a high likelihood of incomplete 
resection (Braunstein and Vick, 1997; Huttner et al.; Pompili et al., 1998).  
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4 DISCUSSION AND FUTURE PERSPECTIVES 
 
Here we (i) showed that there is continuous adult neurogenesis within the human 
hippocampus, (ii) demonstrated that there is no significant induction of neurogenesis in the 
human cerebral cortex in response to stroke, and (iii) established the age and growth 
dynamics of human meningiomas. These findings have several important implications. 
 
First, the functional significance of human hippocampal cell turnover needs to be further 
established (Kempermann et al., 2004b; Spalding et al., 2013; Zhao et al., 2008). 
Hippocampal neurogenesis has been reported to be altered, being either increased or 
decreased, in experimental models as well as in humans depending on pharmacological 
medication and disease (Fabel and Kempermann, 2008; Holmes et al., 2004; Knoth et al., 
2010; Santarelli et al., 2003). Hence, to elucidate hippocampal cell turnover dynamics in 
human disease, specific patient groups with clearly defined diagnoses and treatments need to 
be studied using the radiocarbon-technique (eventually in addition to immunohistochemical 
analyses) to shed light into the debate of whether or not there is altered neurogenesis in these 
settings and which contribution such possibly altered neurogenesis may exert on functional 
outcome (Bergmann et al., 2015; Curtis et al., 2011; Santarelli et al., 2003).  
 
Second, in light of the absence of induction of adult neurogenesis in the human cerebral 
cortex following ischemic stroke (Huttner et al., 2014), is remains unclear whether this 
finding also holds true for other brain regions frequently affected by stroke, notably the basal 
ganglia including the striatum (Lindvall and Kokaia, 2015). These brain structures are 
topographically closely located next to the neurogenic SVZ niche (Kokaia and Lindvall, 
2012). It therefore appears more realistic that newborn neurons may migrate into the 
penumbra of the ischemic lesion, as shown in rodents (Arvidsson et al., 2002). However, 
these studies need to be done in humans using methods such as the radiocarbon-technique, as 
immunohistochemical analyses leave too much room for controversy (Bergmann et al., 
2015). The neurogenic potential of these anatomical areas was recently revived by findings of 
specific striatal neuronal subpopulations showing annual turnover rates >2% (Ernst et al., 
2014). In this regard it appears meaningful and valuable to also assess hippocampal cell 
turnover rates in response to basal ganglia strokes in humans, as increased rates have been 
proposed in animal studies (Lindvall and Kokaia, 2015).  
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Third, the determination of tumor onset and growth dynamics of human meningiomas 
demonstrated that the radiocarbon-technique is feasible also for studying tumor diseases 
(Huttner et al.). Of clinical relevance would be the investigation of cell turnover dynamics in 
gliomas (Venere et al., 2011). These tumors usually are more malignant and cross-over from 
less malignant variants (e.g. WHO°2) to more aggressive and further de-differentiated 
variants, like glioblastoma (WHO°4). A carbondating-approach of tumor tissue (obtained 
upon biopsy or tumor resection) may also allow to birth date specific cancer-initiating stem or 
progenitor cells, which would dramatically increase knowledge of tumor onset and 
progression in gliomas (Lathia et al., 2015; Venere et al., 2011; Weller et al., 2013). In this 
regard the recently established 15N-thymidine infusion method may also allow to study 
human malignant disease in vivo (Alkass et al., 2015; Steinhauser et al., 2012). 
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